Oncodesign Precision Medicine Société anonyme (EPA:ALOPM)
France · Delayed Price · Currency is EUR 0.2410
-0.0110 (-4.37%)
Last updated: Nov 11, 2026, 10:48 AM CET
EPA:ALOPM Revenue
Oncodesign Precision Medicine Société anonyme had revenue of 731.59K EUR in the half year ending June 30, 2026, with 16.46% growth. This brings the company's total for the last twelve months to 1.80M, up 3.65% year-over-year. In the year 2025, Oncodesign Precision Medicine Société anonyme had annual revenue of 1.81M with 11.66% growth. That makes Oncodesign Precision Medicine Société anonyme the 42,414th largest company in the world by revenue and 562nd in France.
Revenue (ttm)
1.80M
Revenue Growth
+3.65%
P/S Ratio
2.55
Revenue / Employee
128.69K
Employees
13
Market Cap
4.60M
Revenue by Segment
- Products Annexed Activities 155.63K 59.6%
- Taxable Services 105.52K 40.4%
Fiscal year ended Dec 31, 2025 See the full EPA:ALOPM breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.81M | 189.29K | 11.66% |
| Dec 31, 2024 | 1.62M | 210.60K | 14.91% |
| Dec 31, 2023 | 1.41M | -6.84M | -82.88% |
| Dec 31, 2022 | 8.25M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.